Postoperative immuno-gene therapy of murine bladder tumor by in vivo administration of retroviruses expressing mouse interferon-γ

Cancer Gene Therapy

Volumn 8, Issue 1, 2001, Pages 73-81

  Shiau, Ai Li ^a   Lin, Chih Yun ^a   Tzai, Tzong Shin ^a   Wu, Chao Liang ^a  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

Author keywords

Bladder cancer; Gene therapy; Interferon ; Retrovirus

Indexed keywords

GAMMA INTERFERON;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLADDER CANCER; CANCER IMMUNOTHERAPY; CANCER SURVIVAL; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; GENE THERAPY; MOUSE; NONHUMAN; POSTOPERATIVE CARE; PRIORITY JOURNAL; RETROVIRUS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIRUS EXPRESSION; VIRUS RECOMBINANT;

ANIMALIA; MURINAE; UNIDENTIFIED RETROVIRUS;

EID: 0035121668     PISSN: 09291903     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.cgt.7700271     Document Type: Article

References (36)

1. Cellular responses to interferon-γ
2. Inhibition of angiogenesis by interleukin-12 is mediated by the interferon-inducible protein 10
3. Mig, the monokine induced by interferon-γ, promotes tumor necrosis in vivo
4. Sensitization of cancer cells treated with cytotoxic drugs to fas-mediated cytotoxicity
5. Activation of the STAT signaling pathway can cause expression of caspase 1 and apoptosis
6. Nuclear integration of JAK/STAT and Ras/AP-1 signaling by CBP and p300
7. Urinary bladder cancer: Mechanisms of development and progression
8. A randomized controlled study of intravesical alpha-2b-interferon in carcinoma in situ of the bladder
9. Combined effect of interleukin-2 and bacillus Calmette-Guerin in the therapy of mice with transitional cell carcinoma
10. Immunotherapy of murine transitional cell carcinoma of the bladder using alpha and gamma interferon in combination with other forms of immunotherapy
11. Sequential immunocytological evaluation of murine transitional cell carcinoma during intralesional bacillus Calmette-Guerin and interleukin-2 immunotherapy
12. Exogenous expression of mouse interferon-γ cDNA in mouse neuroblastoma C1300 cells results in reduced tumorigenicity by augmented antitumor immunity
13. Retroviral vector-mediated gamma-interferon gene transfer into tumor cells generates potent and long-lasting antitumor immunity
14. Reduced tumorigenicity of murine tumor cells secreting gamma-interferon is due to nonspecific host responses and is unrelated to class I major histocompatibility complex expression
15. Vaccinations with tumor cells genetically engineered to produce different cytokines: Effectivity not superior to a classical adjuvant
16. Antimetastatic vaccination of tumor-bearing mice with two types of IFN-gamma gene-inserted tumor cells
17. Cloning and expression of murine immune interferon cDNA
18. A simple and efficient procedure for generating stable expression libraries by cDNA cloning in a retroviral vector
19. Safe and efficient generation of recombinant retroviruses with amphotropic and ecotropic host ranges
20. Serum-free production, concentration and purification of recombinant retroviruses
21. Effect of perioperative chemoimmunotherapy with cyclophosphamide and autologous tumor vaccine in murine MBT-2 bladder cancer
22. Adoptive immunotherapy of syngeneic murine leukemia is enhanced by the combination of recombinant IFN-γ and a tumor-specific cytotoxic T-cell clone
23. Circulating interferon in rabbits after simultaneous intramuscular administration of human alpha and gamma interferons
24. Immunological memory induced by genetically transduced tumor cells
25. In vivo antitumor effect of cytotoxic T lymphocytes engineered to produce interferon-gamma by adenovirus-mediated genetic transduction
26. + T cells against the wild-type tumor: Correlation with antigen presentation capability
27. Immunotherapy via gene therapy: Comparison of the effects of tumor cells transduced with the interleukin-2, interleukin-6, or interferon-γ genes
28. Regression of bladder tumors in mice treated with interleukin-2 gene-modified tumor cells
29. Immunotherapy of bladder cancer with cytokine gene-modified tumor vaccines
30. Development of methods for somatic cell gene therapy directed against viral diseases, using retroviral vectors carrying the murine or human interferon-β coding sequence: Establishment of the antiviral state in human cells
31. Blocking of retroviral infection at a step prior to reverse transcription in cells transformed to constitutively express interferon β
32. Modulating the antitumor immunity of MBT-2 murine bladder tumor bearing mice by postoperative administration of interferon-α
33. A physiological role of interferon (IFN)-β derived from tumor: Tumor growth of a mouse bladder carcinoma line MBT-2 is partially suppressed by autocrine IFN-β
34. Prevention of orthotopic human lung cancer growth by intratracheal instillation of a retroviral antisense K-ras construct
35. Therapeutic effect of a retroviral wild-type p53 expression vector in an orthotopic lung cancer model
36. Systemic gene therapy of murine melanoma using tissue specific expression of the HSVtk gene involves an immune component